查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1802941

NAD+IV 诊所市场预测至 2032 年：按类型、治疗类型、监管状态、应用、最终用户和地区进行的全球分析

NAD+ IV Clinics Market Forecasts to 2032 - Global Analysis By Type, Therapy Type, Regulatory Status, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 NAD+ IV 诊所市场预计在 2025 年价值 5.119 亿美元，到 2032 年将达到 10.4945 亿美元，预测期内复合年增长率为 10.8%。

NAD+静脉注射诊所是专门提供烟碱酰胺腺嘌呤二核苷酸（NAD+）静脉注射的健康中心。这些诊所通常会推广NAD+静脉注射疗法，认为它可以促进细胞健康、提升能量、提高思维清晰度、减轻疲劳，并有助于从药物滥用和压力中恢復。此外，由于NAD+直接进入血液，因此这种疗法被认为比口服补充剂更容易被吸收。

在一项人体静脉注射 NAD+ 研究中，6 小时输注 750 毫克 NAD+ 可使血浆 NAD+ 及其主要代谢物在 6 小时内增加约 400% 的基准，6 小时后尿液 NAD+ 排泄量增加约 538%。

对健康和长寿的需求日益增加

全球对积极健康和延长健康寿命的重视是推动 NAD+ 静脉注射诊所需求的主要因素。随着人口老化，越来越多的人寻求保持活力、精神力量和增强抵抗老龄化的方法。 NAD+ 疗法被推广为一种提升能量、修復细胞和延缓衰老的自然疗法。 NAD+ 疗法吸引了年轻消费者，尤其是健康爱好者和运动员，因为它能够提高注意力、增强耐力并加快恢復速度。与传统补充剂相比，静脉注射可立即吸收，使其成为优质选择。

医疗费用高昂

高昂的治疗费用是NAD+静脉注射诊所市场面临的最大障碍之一。根据剂量和诊所位置的不同，单次NAD+输液的费用可能在几百美元到几千美元之间。由于通常需要多次疗程才能达到持久的疗效，因此其费用很快就会让普通消费者望而却步。这使得NAD+静脉注射疗法成为一种高端或奢侈的健康服务，主要针对富裕人口。与传统的营养补充剂相比，NAD+静脉注射疗法的保险覆盖率很低，这进一步限制了其可近性。

结合整体健康计划

将 NAD+ 静脉注射疗法与更广泛的健康和生活方式计划相结合，代表着一个重大机会。诊所可以将静脉注射与压力管理、健身训练、营养计画和生物骇客工具等服务结合，打造整体健康套餐。透过鼓励持续互动而非一次性服务，这种整合可以提高客户维繫。与健身机构、瑜珈中心和健康疗养院的合作可以提高知名度并吸引新客户。将 NAD+ 定位为整体专案的补充疗法，可以提升其感知价值，将重点从奢华转向生活方式的转变，并吸引寻求个人化、多方面健康和保健解决方案的客户。

科学上被证明是错误的或证据不足

NAD+静脉注射疗法面临的最大风险之一是，未来的科学研究可能无法证实其宣传的有效性。如果大量研究表明，与口服补充剂或安慰剂相比，该疗法几乎没有或根本没有益处，那么该治疗方法可能会失去信誉。这样的发现可能会增加消费者的怀疑、保险拒赔以及监理机构的打击。由于市场很大程度上依赖传闻结果和早期研究，薄弱的证据极有可能损害信任。此外，即使是一项备受瞩目的科学研究对NAD+静脉注射疗法提出质疑，也可能大幅减少需求，损害该行业的地位，并阻碍诊所的进一步投资。

COVID-19的影响：

新冠疫情以多种方式影响了NAD+静脉注射诊所市场。行程限制、封锁以及面对面咨询的减少，暂时减缓了选择性健康治疗和诊所运作的需求。限制非必要服务的法规和人流的减少迫使许多小型诊所关闭。然而，疫情也提升了消费者对復健、免疫健康和预防性保健的兴趣，并带来了关于NAD+静脉注射疗法等疗法的新认识，例如用于能量支持和细胞修復的疗法。疫情过后，随着人们寻求治疗方法疲劳、持续的新冠症状以及增强整体恢復力的疗法，需求激增。这两种影响导致市场转向以增强免疫力和恢復为重点的健康模式。

NAD+ 混合维生素注射剂市场预计将在预测期内成为最大的市场

NAD+混合维生素注射剂预计将在预测期内占据最大的市场占有率，因为它透过将最佳剂量的NAD+与维生素C和B群维生素等辅助维生素相结合，以更实惠的价格分布提供广泛的健康益处。该细分市场吸引了从初次使用者到注重健康的专业人士等广泛的客户群体，因为它能够提供均衡的效果，例如提升能量、修復细胞、促进恢復和增强免疫力，而无需像纯NAD+或高浓度NAD+注射剂那样高昂的成本和强度。此外，混合维生素製剂占诊所提供产品的大多数，由于其提供完整且灵活的解决方案，仍然是消费者中最受欢迎的选择。

预计住宅/家庭用途在预测期内将以最高复合年增长率成长

预计住宅/家庭领域将在预测期内实现最高成长率，这得益于对按需医疗服务、个人化健康和便利性日益增长的需求。越来越多的消费者选择在家中接受 NAD+ 输液，以节省时间、避免去医院就诊，并获得符合自身日程安排且注重舒适度的治疗。高所得、忙碌的专业人士以及患有慢性疾病和新冠后疲劳的患者尤其青睐这种模式。此外，由于行动输液服务供应商和基于应用程式的预约系统提供了灵活性和隐私性，同时扩大了传统医疗机构以外的治疗管道，预计家庭 NAD+ 疗法将实现最高成长。

占比最大的地区：

预计北美将在预测期内占据最大的市场占有率，这得益于健康产业的兴起、消费者对预防性医疗保健意识的不断增强，以及对旨在提高体能、排毒和抗衰老的治疗的强劲需求。美国尤其凭藉其大量的静脉注射治疗诊所、日益增长的行动健康和礼宾服务使用率，以及其重视尖端医疗服务的文化，引领市场。此外，高可支配收入、支持选择性健康治疗的法律规范以及 NAD+ 疗法迅速融入整体健康计划，进一步巩固了北美在全球市场的主导地位。

复合年增长率最高的地区：

预计亚太地区将在预测期内实现最高的复合年增长率，这得益于人们对尖端健康和抗衰老疗法日益增长的认识、快速的都市化以及不断增长的可支配收入。中国、日本、韩国和印度等国家对整体疗法和预防性医疗保健的需求日益增长。该地区不断扩张的私人健康中心网路和医疗旅游业也助长了这一趋势。此外，由于生活方式导致的压力和慢性疾病增多，对尖端、便利、高品质的静脉注射疗法的需求不断增长，预计亚太地区也将实现最高的成长率。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球 NAD+IV 诊所市场（按类型）

  • NAD+混合维生素注射液
  • 纯NAD+注射剂
  • 高浓度NAD+注射液

6. 全球 NAD+IV 诊所市场（依治疗类型）

  • 标准 NAD+ IV 疗法
  • 客製化NAD+静脉注射疗法
  • 辅助性治疗

7. 全球 NAD+IV 诊所市场（依监管状况）

  • 核准的NAD+疗法
  • 实验性或非仿单标示外用途

8. 全球 NAD+IV 诊所市场（按应用）

  • 诊所
  • 医院
  • 住宅/家庭使用

9. 全球 NAD+IV 诊所市场（依最终用户）

  • 健康中心
  • 功能医学实践
  • 移动静脉输液服务

第 10 章。全球 NAD+IV 诊所市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章：企业概况

  • Wellness Lab Inc
  • Mobile IV Medics Inc
  • Fika Infusion+Wellness
  • Azivmedics Inc
  • MD Infusions Inc
  • Premium Health
  • Conciergemdla Inc
  • Longevity Lab
  • Reset IV
  • Seaside Skin Care Inc
  • NADclinic
  • Emirates Hospitals（NAD+IV Therapy Division）
  • ALIV Therapy
  • The Hydration Room
  • The Elixir Clinic
Product Code: SMRC30467

According to Stratistics MRC, the Global NAD+ IV Clinics Market is accounted for $511.90 million in 2025 and is expected to reach $1049.45 million by 2032 growing at a CAGR of 10.8% during the forecast period. NAD+ IV clinics are specialized wellness centers that provide intravenous infusions of nicotinamide adenine dinucleotide (NAD+), a coenzyme naturally found in the body that plays a critical role in cellular energy production and repair. NAD+ IV therapy is usually promoted by these clinics as a means of promoting cellular health, boosting energy, improving mental clarity, lowering fatigue, and aiding in the healing process from substance abuse or stress. Moreover, the treatment is thought to have a higher absorption rate than oral supplements because NAD+ is given straight into the bloodstream.

According to a human pilot study of IV NAD+ infusion, during a 6-hour 750 mg NAD+ intravenous drip, plasma NAD+ and key metabolites rose to ~400% of baseline by hour 6, urinary NAD+ excretion increased ~538% at 6 hours, and no serious adverse events were observed in the small cohort.

Market Dynamics:

Driver:

Increasing demand for wellness & longevity

The worldwide emphasis on proactive wellness and healthspan extension is a major factor driving the demand for NAD+ IV clinics. More and more people are looking for ways to preserve their vitality, mental acuity, and resistance to age-related decline as populations get older. NAD+ therapy is promoted as a natural means of increasing vitality, repairing cells, and delaying the observable aging process. The therapy appeals to younger consumers, particularly wellness enthusiasts and athletes, because it promotes better focus, increased stamina, and a quicker recovery. IV delivery is positioned as a premium option because it provides immediate absorption, in contrast to traditional supplements.

Restraint:

High treatment costs

The high cost of therapy is one of the biggest barriers to the market for NAD+ IV clinics. Depending on the dosage and clinic location, the cost of a single NAD+ infusion session can vary from a few hundred to several thousand dollars. Costs soon become unaffordable for typical consumers because treatments frequently call for several sessions to produce long-lasting effects. This presents NAD+ IV therapy as a high-end or luxury wellness service that is primarily available to wealthy customers. Its infrequent insurance coverage, in contrast to that of conventional nutritional supplements, further restricts affordability.

Opportunity:

Combining with Programs for Holistic Wellness

Integrating NAD+ IV therapy with larger wellness and lifestyle initiatives presents a significant opportunity. Clinics can create holistic wellness packages by combining infusions with services like stress management, fitness training, nutrition planning, and biohacking tools. By promoting ongoing interaction as opposed to one-time services, this integration increases customer retention. Collaborations with fitness facilities, yoga centers, and wellness retreats can increase visibility and attract new customers. By positioning NAD+ as a complementary therapy in holistic programs, its perceived value is increased, the emphasis is shifted from luxury to lifestyle transformation, and it attracts customers looking for individualized, multifaceted health and wellness solutions.

Threat:

Scientific rebuttal or insufficient proof

The potential for future scientific studies to fail to confirm the benefits of NAD+ IV therapy as advertised is one of the biggest risks to the treatment. The therapy may lose credibility if extensive research reveals little to no benefit when compared to oral supplements or placebo treatments. Such discoveries would increase consumer skepticism, insurance rejection, and regulatory crackdowns. Weak evidence has a high risk of undermining confidence because a large portion of the market depends on anecdotal results and early-stage research. Moreover, a single high-profile scientific study that casts doubt on NAD+ IV therapy could significantly reduce demand, harming the industry's standing and deterring further clinic investment.

Covid-19 Impact:

The COVID-19 pandemic affected the market for NAD+ IV clinics in a variety of ways. Travel restrictions, lockdowns, and fewer in-person medical visits momentarily slowed the demand for elective wellness treatments and clinic operations. Regulations restricting non-essential services and dwindling foot traffic forced the closure of numerous small clinics. However, the pandemic also increased consumer interest in recovery, immune health, and preventive wellness, bringing new knowledge of therapies such as NAD+ IV for energy support and cellular repair. As people looked for remedies for fatigue, long-lasting COVID symptoms, and general resilience, demand sharply increased after the pandemic. The market shifted toward wellness models that emphasize immunity-boosting and recovery as a result of these two effects.

The NAD+ mixed vitamin injections segment is expected to be the largest during the forecast period

The NAD+ mixed vitamin injections segment is expected to account for the largest market share during the forecast period because they offer broader wellness benefits at a more affordable price point by combining supportive vitamins like vitamin C and B-complex with moderate doses of NAD+. Because it provides balanced results like increased energy, cellular repair, recovery, and immune support without the higher costs or intensity of pure or high-concentration NAD+ infusions, this segment appeals to a wide range of clients, from first-time users to health-conscious professionals. Moreover, mixed vitamin formulations dominate clinic offerings and continue to be the most popular choice among consumers because they offer a complete, adaptable solution.

The residential/home use segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the residential/home use segment is predicted to witness the highest growth rate, driven by the growing need for on-demand medical services, personalized wellness, and convenience. In order to save time, avoid clinical visits, and receive comfort-focused treatments that fit their schedules, consumers are increasingly choosing to receive NAD+ infusions at home. High earners, busy professionals, and patients dealing with chronic wellness issues or post-COVID fatigue are particularly fond of this model. Additionally, home-based NAD+ therapy is the market with the highest anticipated growth rate because it provides flexibility and privacy while extending access outside of conventional healthcare settings, aided by mobile IV service providers and app-based booking systems.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, backed by a thriving wellness sector, a high level of consumer awareness regarding preventive healthcare, and a robust demand for treatments that improve performance, detox, and anti-aging. In particular, the United States leads because of the large number of specialized IV therapy clinics, the increasing use of mobile wellness and concierge services, and a culture that values cutting-edge medical advancements. Furthermore, North America's dominance in the global market is further supported by higher disposable incomes, regulatory frameworks that are supportive of elective wellness treatments, and the quick integration of NAD+ therapy into holistic health programs.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by growing awareness of cutting-edge wellness and anti-aging treatments, fast urbanization, and rising disposable incomes. The demand for holistic therapies and preventive healthcare is rising in nations like China, Japan, South Korea, and India as working professionals and younger populations look for recovery-focused and energy-boosting solutions. This trend is further supported by the region's growing network of private wellness centers and medical tourism industry. Moreover, Asia-Pacific's demand for cutting-edge, easily accessible, and high-quality IV therapies makes it the region with the fastest rate of growth as stress and chronic illnesses linked to lifestyle choices increase.

Key players in the market

Some of the key players in NAD+ IV Clinics Market include Wellness Lab Inc, Mobile IV Medics Inc, Fika Infusion + Wellness, Azivmedics Inc, MD Infusions Inc, Premium Health, Conciergemdla Inc, Longevity Lab, Reset IV, Seaside Skin Care Inc, NADclinic, Emirates Hospitals (NAD+ IV Therapy Division), ALIV Therapy, The Hydration Room and The Elixir Clinic.

Key Developments:

In June 2025, Hydration Room proudly announces the opening of its newest clinic at Victoria Gardens in Rancho Cucamonga marking its first location in San Bernardino County. This opening marks the next step in Hydration Room's statewide expansion, with multiple Bay Area clinics launching later this summer.

In March 2025, Longevity solution provider NADclinic has partnered with Intuisse, which creates NAD+ skincare. The partnership will see both brands offering science-backed Nicotinamide Adenine Dinucleotide+ (NAD+) beauty products and wellness solutions across their ecommerce platforms. In a strategic collaboration, each brand will retail the other's products to improve accessibility to advanced NAD+ therapies.

Types Covered:

  • NAD+ Mixed Vitamin Injections
  • Pure NAD+ Injection
  • High-Concentration NAD+ Injection

Therapy Types Covered:

  • Standard NAD+ IV Therapy
  • Customized NAD+ IV Therapy
  • Adjunctive Therapies

Regulatory Status Covered:

  • Approved NAD+ Therapies
  • Experimental or Off-Label Use

Applications Covered:

  • Clinics
  • Hospitals
  • Residential/Home Use

End Users Covered:

  • Wellness Centers
  • Functional Medicine Practices
  • Mobile IV Services

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global NAD+ IV Clinics Market, By Type

  • 5.1 Introduction
  • 5.2 NAD+ Mixed Vitamin Injections
  • 5.3 Pure NAD+ Injection
  • 5.4 High-Concentration NAD+ Injection

6 Global NAD+ IV Clinics Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Standard NAD+ IV Therapy
  • 6.3 Customized NAD+ IV Therapy
  • 6.4 Adjunctive Therapies

7 Global NAD+ IV Clinics Market, By Regulatory Status

  • 7.1 Introduction
  • 7.2 Approved NAD+ Therapies
  • 7.3 Experimental or Off-Label Use

8 Global NAD+ IV Clinics Market, By Application

  • 8.1 Introduction
  • 8.2 Clinics
  • 8.3 Hospitals
  • 8.4 Residential/Home Use

9 Global NAD+ IV Clinics Market, By End User

  • 9.1 Introduction
  • 9.2 Wellness Centers
  • 9.3 Functional Medicine Practices
  • 9.4 Mobile IV Services

10 Global NAD+ IV Clinics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Wellness Lab Inc
  • 12.2 Mobile IV Medics Inc
  • 12.3 Fika Infusion + Wellness
  • 12.4 Azivmedics Inc
  • 12.5 MD Infusions Inc
  • 12.6 Premium Health
  • 12.7 Conciergemdla Inc
  • 12.8 Longevity Lab
  • 12.9 Reset IV
  • 12.10 Seaside Skin Care Inc
  • 12.11 NADclinic
  • 12.12 Emirates Hospitals (NAD+ IV Therapy Division)
  • 12.13 ALIV Therapy
  • 12.14 The Hydration Room
  • 12.15 The Elixir Clinic

List of Tables

  • Table 1 Global NAD+ IV Clinics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 4 Global NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 5 Global NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 6 Global NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 7 Global NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 8 Global NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 9 Global NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 10 Global NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 11 Global NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 12 Global NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 13 Global NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 14 Global NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 15 Global NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 16 Global NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 17 Global NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 19 Global NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 20 Global NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
  • Table 21 North America NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
  • Table 22 North America NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 23 North America NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 24 North America NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 25 North America NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 26 North America NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 27 North America NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 28 North America NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 29 North America NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 30 North America NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 31 North America NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 32 North America NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 33 North America NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 34 North America NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 35 North America NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 36 North America NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 37 North America NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 North America NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 39 North America NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 40 North America NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
  • Table 41 Europe NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
  • Table 42 Europe NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 43 Europe NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 44 Europe NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 45 Europe NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 46 Europe NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 47 Europe NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 48 Europe NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 49 Europe NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 50 Europe NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 51 Europe NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 52 Europe NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 53 Europe NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 54 Europe NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 55 Europe NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 56 Europe NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 57 Europe NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 58 Europe NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 59 Europe NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 60 Europe NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
  • Table 61 Asia Pacific NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
  • Table 62 Asia Pacific NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 63 Asia Pacific NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 64 Asia Pacific NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 65 Asia Pacific NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 66 Asia Pacific NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 67 Asia Pacific NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 68 Asia Pacific NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 69 Asia Pacific NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 70 Asia Pacific NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 71 Asia Pacific NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 72 Asia Pacific NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 73 Asia Pacific NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 74 Asia Pacific NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 75 Asia Pacific NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 76 Asia Pacific NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 77 Asia Pacific NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 78 Asia Pacific NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 79 Asia Pacific NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 80 Asia Pacific NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
  • Table 81 South America NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
  • Table 82 South America NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 83 South America NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 84 South America NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 85 South America NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 86 South America NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 87 South America NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 88 South America NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 89 South America NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 90 South America NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 91 South America NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 92 South America NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 93 South America NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 94 South America NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 95 South America NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 96 South America NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 97 South America NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 98 South America NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 99 South America NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 100 South America NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
  • Table 101 Middle East & Africa NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
  • Table 102 Middle East & Africa NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
  • Table 103 Middle East & Africa NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
  • Table 104 Middle East & Africa NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
  • Table 105 Middle East & Africa NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
  • Table 106 Middle East & Africa NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 107 Middle East & Africa NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
  • Table 108 Middle East & Africa NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
  • Table 109 Middle East & Africa NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
  • Table 110 Middle East & Africa NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
  • Table 111 Middle East & Africa NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
  • Table 112 Middle East & Africa NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
  • Table 113 Middle East & Africa NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
  • Table 114 Middle East & Africa NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 115 Middle East & Africa NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 116 Middle East & Africa NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
  • Table 117 Middle East & Africa NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
  • Table 118 Middle East & Africa NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
  • Table 119 Middle East & Africa NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
  • Table 120 Middle East & Africa NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)